P08581 (MET_HUMAN) Homo sapiens (Human)

Hepatocyte growth factor receptor UniProtKBInterProSTRINGInteractive Modelling

1390 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3); 1 identical sequence: Homo sapiens: A0A024R759

Available Structures

100 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
107_A07 Fab in complex with fragment of the Met receptor Heteromer
NAG;25-740
Assess
Cryo-EM structure of 2:2 c-MET/HGF holo-complex Heteromer
P14210;
SGN;26-740
Assess
Cryo-EM map of the c-MET II/HGF I/HGF II (K4 and SPH) sub-complex Heteromer
P14210;
SGN;26-738
Assess
Cryo-EM structure of the c-MET II/HGF I complex bound with HGF II in a rigid conformation Heteromer
P14210;
SGN;26-738
Assess
MET receptor in complex with InlB internalin domain and DARPin A3A Heteromer
P0DQD3;
40-740
Assess
Structure of the human receptor tyrosine kinase Met in complex with the Listeria monocytogenes inva… Heteromer
P0DQD2;
42-741
Assess
Cryo-EM structure of 1:1 c-MET I/HGF I complex after focused 3D refinement of holo-complex Heteromer
P14210;
SGN;26-654
Assess
Structure of the human receptor tyrosine kinase Met in complex with the Listeria monocytogenes inva… Heteromer
P0DQD2;
42-658
Assess
Crystal structure of Onartuzumab Fab in complex with MET and HGF-beta Heteromer
P14210;
NAG;39-564
Assess
Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP2.3 Heteromer
P14210;
39-564
Assess
Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP.14 Heteromer
P14210;
NAG;1PE;40-564
Assess
Crystal structure of anti-MET Fab arm of amivantamab in complex with human MET Heteromer
NAG;NAG;NAG;FMT;40-564
Assess
The Crystal Structure of HGF beta-chain in Complex with the Sema Domain of the Met Receptor. Heteromer
P14210;
40-564
Assess
Cryo-EM structure of 2:2 c-MET/NK1 complex Heteromer
P14210;
33-557
Assess
Crystal structure of Sema domain of the Met receptor in complex with FAB Heteromer
41-517
Assess
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in c-Met Heteromer
P22681;
998-1005
Assess
DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX Heteromer
P62993;
1355-1359
Assess
Crystal structure of the c-Met kinase domain in complex with a pyrazolone inhibitorhomo-2-mer75H;1050-1350
Assess
Structure of c-Met with pyrimidone inhibitor 50homo-2-merMT4;1054-1351
Assess
Structure of c-Met with pyrimidone inhibitor 7homo-2-merMT3;1054-1351
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN C…homo-2-mer5B4;1050-1346
Assess
MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibodymonomer84M;GOL;CL;1029-1360
Assess
MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibodymonomer84S;CL;1029-1360
Assess
MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibodymonomer84P;CL;1029-1360
Assess
Crystal structure of human c-Met kinase domain with its inhibitormonomerDF6;CL;1024-1352
Assess
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met in c…monomerKSA;1050-1360
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-METmonomer1050-1360
Assess
Structure of MET receptor tyrosine kinase in complex with inhibitor SGX-523monomerCL;SX8;1050-1360
Assess
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-MET in c…monomerCKK;1050-1360
Assess
Structure of MET receptor tyrosine kinase in complex with ATPmonomerMG;CL;ATP;1051-1360
Assess
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in c…monomer320;1051-1360
Assess
c-Met Kinase in Complex with NVP-BVU972monomer3QT;CL;1052-1360
Assess
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in c…monomer319;1052-1360
Assess
Structure of Mutant(Y1248L) MET receptor tyrosine kinase in complex with inhibitor SGX-523monomerCL;SX8;1050-1356
Assess
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in c…monomerL8V;1054-1360
Assess
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in c…monomer1FN;1054-1360
Assess
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in c…monomer353;1055-1360
Assess
Crystal structure of c-Met in complex with LY2801653monomerL1X;1045-1346
Assess
Structure of the apo MET receptor kinase in the dually-phosphorylated, activated statemonomer1048-1348
Assess
Structure of dually phosphorylated c-MET receptor kinase in complex with an MK-8033 analogmonomer1JC;1048-1348
Assess
Crystal structure of c-Met in complex with pyrazolone inhibitor 26monomer03X;1051-1351
Assess
Crystal structure of c-Met in complex with pyrazolone inhibitor 58amonomer044;1051-1351
Assess
Structural Characterization of autoinhibited c-Met kinasemonomer1046-1346
Assess
Structure of dually phosphorylated c-MET receptor kinase in complex with an MK-2461 analogmonomerM61;1048-1348
Assess
Structure of dually-phosphorylated MET receptor kinase in complex with an MK-2461 analog with speci…monomerQ6W;1050-1348
Assess
Crystal structure of c-Met mutant Y1230H in complex with compound 14monomerCL;62E;1057-1355
Assess
Human c-Met Kinase in complex with quinoxaline inhibitormonomerIHX;GBL;1052-1349
Assess
Crystal structure of the catalytic domain of c-Met kinase in complex with ARQ 197monomerM97;1049-1346
Assess
human c-MET kinase domain complexed with 6-benzyloxyquinoline inhibitormonomerCL;IPA;DFQ;1063-1360
Assess
Crystal structure of c-Met in complex with AMG 337monomer5T1;1052-1348
Assess
Crystal structure of CMET in complex with novel inhibitormonomerDWF;1052-1346
Assess
Crystal structure of c-Met kinase domain in complex with LXM108monomer66L;1052-1346
Assess
Crystal structure of D1228V cMET bound by foretinibmonomer88Z;1052-1346
Assess
Crystal structure of c-Met in complex with (R)-5-(8-fluoro-3-(1-fluoro-1-(3-methoxyquinolin-6-yl)et…monomer46G;1051-1345
Assess
Crystal structure of c-Met in complex with (S)-5-(8-fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)e…monomer44X;1052-1346
Assess
Crystal structure of c-Met with triazolopyridazine inhibitor 13monomerB2D;1052-1346
Assess
Crystal structure of c-Met in complex with triazolopyridazine inhibitor 2monomer0JJ;1052-1346
Assess
x-ray structure of c-Met with inhibitor.monomerAM7;1057-1351
Assess
X-ray Structure of c-Met kinase in complex with inhibitor (S)-3-(1-(1H-pyrrolo(2,3-b)pyridin-3-yl)e…monomer5TF;1052-1345
Assess
CRYSTAL STRUCTURE OF CMET WT with compound 3monomer63B;1063-1356
Assess
X-ray Structure of PF-04217903 bound to the kinase domain of c-MetmonomerKRW;1052-1345
Assess
Crystal structure of C-MET kinase domain in complex with 4-((6-(4- fluorophenyl)-(1,2,4)triazolo(4,…monomerF47;1052-1345
Assess
CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH CMPD.monomer63K;1063-1356
Assess
X-ray Structure of PF-02341066 bound to the kinase domain of c-MetmonomerVGH;1052-1345
Assess
Crystal structure of c-Met in complex with triazolopyridinone inhibitor 3monomer0JK;1053-1346
Assess
Crystal structure of c-Met in complex with triazolopyridinone inhibitor 24monomer0JL;1053-1346
Assess
X-ray Structure of c-Met kinase in complex with inhibitor (S)-6-(1-(6- (1-methyl-1H-pyrazol-4-yl)-(…monomerW9Z;1052-1345
Assess
Crystal structure of c-Met in complex with naphthyridinone inhibitor 5monomer5SZ;1053-1345
Assess
Crystal structure of C-MET kinase domain in complex with 4-(3-((1H- pyrrolo(2,3-b)pyridin-3-yl)meth…monomer4K0;1052-1344
Assess
X-ray Structure of c-Met with triazolopyridazine Inhibitor.monomerL5G;1054-1346
Assess
Structure of the kinase domain of c-Met bound to XL880 (GSK1363089)monomer88Z;1053-1345
Assess
Crystal structure of c-Met-M1250T in complex with SAR125844.monomer63K;1064-1356
Assess
Crystal structure of c-MET bound by compound S1monomerSVT;DMS;SO4;1055-1346
Assess
Crystal structure of c-MET bound by compound 6monomerSWN;1055-1346
Assess
X-ray structure of c-Met with triazolopyridazine inhibitor.monomerLKG;1055-1346
Assess
Crystal structure of c-MET bound by compound 7monomerSWK;1055-1346
Assess
Human c-Met Kinase in complex with azaindole inhibitormonomerZZY;GBL;1055-1346
Assess
Crystal structure of c-Met L1195V in complex with SAR125844monomer63K;1065-1356
Assess
Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitorsmonomer3E8;GBL;1055-1345
Assess
Crystal structure of CMET in complex with novel inhibitormonomer5QQ;1055-1345
Assess
Crystal structure of c-MET bound by compound 1monomerSV5;SO4;1055-1344
Assess
Crystal structure of c-MET bound by compound 8monomerSW8;1055-1344
Assess
Crystal structure of c-MET bound by compound 5monomerDMS;SV8;1055-1344
Assess
Crystal structure of c-MET bound by compound 9monomerSW5;1055-1344
Assess
CRYSTAL STRUCTURE OF c-MET IN COMPLEX WITH NOVEL INHIBITORmonomer6TD;1057-1345
Assess
Crystal structure of c-MET bound by compound 3monomerSWB;1057-1344
Assess
Crystal structure of C-MET kinase domain in complex with N'-((3Z)-4- chloro-7-methyl-2-oxo-1,2-dihy…monomer6XP;1059-1345
Assess
X-ray Structure of PHA-00665752 bound to the kinase domain of c-MetmonomerPFY;1059-1345
Assess
X-ray Structure of c-Met kinase in complex with inhibitor 6-((6-(4- fluorophenyl)-(1,2,4)triazolo(4…monomer6XE;1059-1345
Assess
Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitormonomer3EH;7PE;1062-1346
Assess
Crystal structure of wild-type cMET bound by foretinibmonomerCL;88Z;1062-1345
Assess
Crystal structure of D1228V cMET bound by BMS-777607monomer353;GOL;1062-1344
Assess
Crystal structure of c-MET bound by compound 2monomerSVK;CL;SO4;1062-1344
Assess
Crystal structure of cMET in complex with novel inhibitormonomer0J8;1064-1344
Assess
C-Met in complex with OSI ligandmonomer1RU;GBL;1064-1344
Assess
Crystal structure of CMET in complex with novel inhibitormonomer0J3;1064-1344
Assess
X-ray structure of SU11274 bound to c-MetmonomerAM8;1067-1346
Assess
Crystal structure of wild-type cMET bound by savolitinibmonomerV0L;1068-1346
Assess
Crystal structure of c-MET bound by compound 4monomerEDO;SVH;1067-1344
Assess
Solution structure of the PSI domain from the Met receptormonomer519-562
Assess

3 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.796gcu.1.A40-740
100.00
Assess
monomer0.767mo7.1.D26-740
100.00
Assess
monomer0.686jrx.1.A1075-1344
37.97
Assess

6 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer0.796gcu.1.A40-740
100.00
Assess
Isoform 2monomer0.767mo7.1.D26-740
100.00
Assess
Isoform 2monomer0.732uzy.1.B42-741
99.72
Assess
Isoform 2monomer0.686jrx.1.A1093-1362
37.97
Assess
Isoform 3monomer0.796gcu.1.A40-740
100.00
Assess
Isoform 3monomer0.767mo7.1.B26-738
98.95
Assess

Alignments